Dr. Jamieson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 858-822-6276Fax+1 858-822-6288
Education & Training
Stanford Health CareFellowship, Blood & Bone Marrow Transplant, 1999 - 2002
University of British ColumbiaClass of 1995
Certifications & Licensure
CA State Medical License 1999 - 2026- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctors:San Diego Area Castle Connolly, 2013
- Top Doctors:Southern California Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Join now to see all
Clinical Trials
- Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF Start of enrollment: 2011 Jun 01
- A Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment Cessation Start of enrollment: 2013 Aug 12
- UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia Start of enrollment: 2014 Aug 08
- Join now to see all
Publications & Presentations
PubMed
- Impact of Recent Translational and Therapeutic Developments on Clinical Course of BCR::ABL1-Positive and -Negative Myeloproliferative Neoplasms.Tariq I Mughal, John Mascarenhas, Raajit K Rampal, Prithviraj Bose, Thomas Lion
Hematological Oncology. 2025-01-01 - 1 citationsLong-term clinical and safety outcomes from a single-site phase 1 study of neural stem cell transplantation for chronic thoracic spinal cord injury.Joel R Martin, Daniel Cleary, Mickey E Abraham, Michelle Mendoza, Betty Cabrera
Cell Reports. Medicine. 2024-12-17 - RNA Modifications Shape Hematopoietic Stem Cell Aging: Beyond the Code.Inge van der Werf, Jenna Sneifer, Catriona Jamieson
FEBS Letters. 2024-11-01
Abstracts/Posters
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Cirmtuzumab, a ROR1 Targeted Mab, Reverses Cancer Stemness, and Its Combination with Ibrutinib Is Safe and Effective: Planned Analysis of the Cirll Phase 1/2 Trial for...Catriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Results from a Phase 2 Study of Navitoclax in Combination with Ruxolitinib in Patients with Primary or Secondary MyelofibrosisCatriona Jamieson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Inflammatory Cytokine Responsive Enzymatic Mutagenesis Fuels Myeloproliferative Neoplasm Pre-Leukemia Stem Cell Evolution61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
- RNA Modifications in Hematologic Malignancies60th American Society of Hematology Annual Meeting - 12/2/2018
- RNA Modifications in Hematology60th American Society of Hematology Annual Meeting - 12/1/2018
- Join now to see all
Press Mentions
Targeting Therapy-Resistant Pediatric Acute Myeloid LeukemiaMarch 8th, 2023- UC San Diego’s Astrobiotechnology Hub to Drive Drug Discovery in SpaceFebruary 28th, 2023
- Small Molecule Drug Reverses ADAR1-Induced Cancer Stem Cell Cloning CapacityFebruary 16th, 2023
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
